A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve)
Clinical trial NCT04581733 · WITHDRAWN
Trial details
- NCT number
- NCT04581733
- Sponsor
- Zogenix MDS, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2025-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.